Tema ETFs’s Regeneron Pharmaceuticals REGN Stock Holding History

Tema ETFs’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.07M	Sell	2,736 -2,745	-50%	-$2.07M	0.08%	183
2026 Q2	$3.42M	Buy	5,481 +121	+2%	+$82.4K	0.11%	135
2026 Q1	$4.14M	Buy	5,360 +498	+10%	+$381K	0.28%	93
2025 Q4	$3.75M	Sell	4,862 -509	-9%	-$346K	0.29%	98
2025 Q3	$3.02M	Buy	5,371 +64	+1%	+$36.2K	0.25%	121
2025 Q2	$2.79M	Buy	5,307 +1,007	+23%	+$562K	0.74%	49
2025 Q1	$2.73M	Sell	4,300 -1,549	-26%	-$1.07M	0.81%	41
2024 Q4	$4.17M	Buy	+5,849	New	+$4.91M	1.73%	22

Other funds holding REGN

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

Tema ETFs's REGN Position: Q3 2026 in Review

Tema ETFs reduced its Regeneron Pharmaceuticals (REGN) stake by 50% in Q3 2026, selling an estimated $2.07M and leaving 2,736 shares worth $2.07M. The position accounts for 0.08% of the portfolio, ranked #183.

Tema ETFs first reported a position in REGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.17M in Q4 2024. 218 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Tema ETFs held 2,736 shares of Regeneron Pharmaceuticals worth $2.07M as of Q3 2026.
Tema ETFs sold 2,745 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $2.07M.
Regeneron Pharmaceuticals made up 0.08% of Tema ETFs's portfolio in Q3 2026, its #183 holding.
Tema ETFs first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
Tema ETFs's Regeneron Pharmaceuticals position peaked at $4.17M in Q4 2024.
218 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.